Xealth, a Seattle-based digital prescribing platform has raised $11 million in Series A funding from McKesson Ventures, Novartis, Philips, and ResMed. Existing investors Threshold Ventures (formerly DFJ Venture), Providence Ventures, UPMC and Froedtert and the Medical College of Wisconsin health network also participated in the round.Xealth BackgroundSpun out of Providence St. Joseph Health in 2017, Xealth enables clinicians to prescribe and monitor digital healthcare content, apps, devices, and
Read More
Providence Ventures Closes $150M Fund to Foster Healthcare Innovation
Providence Ventures, the Venture capital arm of Providence St. Joseph Health (PSJH) has announced a second $150 million healthcare venture capital and growth equity fund. Founded in 2014, Providence Ventures manages $300 million in venture capital funds on behalf of Providence St. Joseph Health (PSJH), the nation's third-largest health system. Providence Ventures Second Health Fund Focus AreasProvidence Venture's investment strategy is focused on identifying the best opportunities that align
Read More
Digital Health Startup Incubated at Providence Lands $8.5M for Digital Prescription Platform
Xealth, a digital health startup incubated within Providence’s Digital Innovation program has raised $8.5 million in funding led by DFJ to launch its digital prescription platform. The funding also included participation from leading healthcare organizations including Providence, UPMC, Hennepin, and Froedtert.Xealth’s digital prescribing and analytics platform is already being used by two of the largest not-for-profit healthcare systems in the US—Seattle-based Providence and Pittsburgh-based
Read More